LexDanaLexDanabeta
Inventor

MINGZONG LI

Inventor
US

Overview

2→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry14%
PatentTitleYear
12,077,534Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer202411,524,960Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to AGIOS PHARMACEUTICALS INC (1)· patent assignee history
2022Patents assigned to SERVIER PHARMACEUTICALS LLC (1)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to LES LABORATOIRES SERVIER SAS (1)· patent assignee history
2024Patents assigned to SERVIER LAB (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AGIOS PHARMACEUTICALS INC12022
LES LABORATOIRES SERVIER SAS12024
SERVIER LAB12024
SERVIER PHARMACEUTICALS LLC12022
Locations
LocationPatentsSpan
US22022–2024